DIGITALDX
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video
Picture
Debbie Lin, PhD
Picture
  • Corporate Venture Digital Health Investor
  • Board Director -launched the fund's digital strategy in North America
  • VP of Strategic Partnerships Precision Oncology ​
  • Global Corporate Strategy and Development Director -Launched two new international business models 
  • Real World Evidence, market access, and healthcare enterprise sales expert
  • Led US Corporate Social Responsibility program 
  • Lecturer Stanford University School of Medicine
  • Guest Lecturer: Leadership, Healthcare Innovation, Ventures
  • Scientist- PhD in Clinical Pharmacology and bioinformatics, + background in Decision Systems Engineering and Health Policy
Dr. Lin is Vice President - Strategic Partnerships at Caris Life Sciences. Prior to her role at Caris, she was an Executive Director at Boehringer Ingelheim's Venture Fund. Having spent over 14 years at Boehringer Ingelheim, Dr. Lin held various roles in the US and internationally, including leading US digital healthcare efforts and investments, board directorship, and in global strategy and corporate development, and supporting drug launches in field-based roles in Health Economics and Medical Affairs.

She has earned a reputation as an executive deeply passionate and committed to steering her organization in new business strategy and development, intrapreneurial and strategic thinking, and executional excellence. She is an empathetic and dynamic leader who takes pride in helping to transform large organizations and pushing the envelope in new business strategies. A Life Science & Digital Health Investor and Pharmaceutical Executive, Dr. Lin is also committed to supporting women and minorities in science and leadership.

Dr. Lin holds a Ph.D. in Pharmacogenomics and Bioinformatics from the University of California San Francisco, a BS in Chemistry and Public Policy from Pomona College, and an MSc. Eng. from Stanford University School of Engineering.
Disclaimer
Terms & Conditions
Privacy Policy
Investment Inquiries
Contact
Picture
Picture
Picture
 Copyright © 2022 All Rights Reserved
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video